Dianthus Therapeutics | Los Gastos De Explotación



Operating Expenses Cambio Fecha
Adcock Ingram Holdings ZAR 4.42B 268.95M 2024-06
Alaunos Therapeutics USD 1.15M 20K 2024-09
Avita Medical AUD 28.36M 2.44M 2024-12
Celltrion KRW 674.25B 128.01B 2024-09
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Ecofibre AUD 12.31M 44.07M 2024-06
IQVIA Holdings USD 3.33B 14M 2024-12
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 311.35M 170.35M 2024-12
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 10.35M 17.73M 2024-06
Moderna USD 2.21B 280M 2024-12
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Organon & Co USD 1.46B 88M 2024-12
Pharma Mar EUR 43.47M 3.3M 2024-12
Qiagen NV USD 377.04M 4.6M 2024-12
Revvity USD 610.62M 24.72M 2024-12
Sartorius EUR 725.4M 29M 2024-09
Sino Biopharmaceutical CNY 11.66B 5.46B 2024-12
Tectonic Therapeutic USD 13.99M 5.65M 2024-12
Tilray USD 253.17M 16.55M 2024-11
Viatris USD 3.55B 84.2M 2024-12
Xeris Pharmaceuticals USD 58.42M 8.74M 2024-12
Zz Pientze Pharmaceu 1.67B 86.7M 2024-09



Dianthus Therapeutics Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.